Does UnitedHealthcare Cover Mounjaro?
The verdict
Conditional on most plans
UnitedHealthcare (OptumRx) covers Mounjaro for type 2 diabetes with prior authorization — not for weight loss. OptumRx covers tirzepatide-for-diabetes (Mounjaro) as a standard T2D prior auth, while tirzepatide-for-weight-loss (Zepbound) is treated as a distinct, BMI-gated, employer-benefit-dependent category. Tier varies by plan — verify on the UHC/OptumRx formulary. Mounjaro is not in the 2026 Medicare GLP-1 Bridge.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with UnitedHealthcare using your member ID.
Key facts
UnitedHealthcare uses OptumRx as its PBM. OptumRx covers Mounjaro for confirmed type 2 diabetes with PA; weight-loss GLP-1s (Wegovy, Zepbound) are a separate BMI-gated, employer-benefit-dependent category.
OptumRx formulary documentation, 2025–2026
Mounjaro (tirzepatide) is FDA-approved for glycemic control in adults with type 2 diabetes only. The weight-loss tirzepatide product is Zepbound, which requires BMI of 30+ (or 27+ with comorbidity) for coverage.
FDA, Mounjaro and Zepbound Prescribing Information, 2023–2024
The 2026 Medicare Part D out-of-pocket cap is $2,100. Most continuous Mounjaro users for diabetes reach the cap within 2-3 months and pay $0 for the rest of the year.
CMS.gov, Medicare Part D Redesign 2026
Medicare vs. commercial coverage
Whether UnitedHealthcare covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
UnitedHealthcare Medicare Part D and Medicare Advantage plans cover Mounjaro for type 2 diabetes only — not weight loss — with prior authorization via OptumRx. The 2026 Part D out-of-pocket cap is $2,100; most continuous users reach it within 2-3 months and pay $0 thereafter. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT in the 2026 Medicare GLP-1 Bridge, which covers weight-loss-approved products only. The Lilly savings card is not usable by Medicare or Medicare Advantage beneficiaries.
Commercial / Employer
Group & marketplace plans
UnitedHealthcare Commercial/Employer plans cover Mounjaro for type 2 diabetes via OptumRx with a confirmed T2D diagnosis and prior authorization. Off-label weight-loss use is not covered. Weight-loss GLP-1s (Wegovy, Zepbound) require BMI of 30 or higher (or 27 or higher with a qualifying comorbidity) and are handled as a separate employer-benefit-dependent category — not the same as Mounjaro's diabetes coverage. ACA/Individual: covered for T2D with PA; weight-loss GLP-1s commonly excluded. Medicaid (UHC Community Plan): covered for T2D with PA; not covered for weight loss. The Lilly savings card ($25/month with coverage; $499/month without) applies to commercially insured patients only, not government programs.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month; up to 13 fills; expires 12/31/2026). Not available to Medicare or Medicaid beneficiaries.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial with coverage: Lilly savings card as low as $25/month. Medicare Part D: 25% coinsurance after deductible until the $2,100 OOP cap; most continuous users reach the cap in 2-3 months. MFN price $245/month mid-2026 for Medicare. UHC Community Plan Medicaid: nominal cost-share.
Typical monthly copay once prior authorization is approved.
All figures are estimates; actual cost-share varies by plan tier and pharmacy. Tier varies by UHC plan — verify on UHC.com or the OptumRx formulary.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Mounjaro on the UHC/OptumRx formulary for your plan
Visit uhc.com or the OptumRx drug lookup tool for your specific commercial, Medicare, or Medicaid plan. Search for 'Mounjaro' or 'tirzepatide' and confirm it is listed for diabetes (ICD-10 E11.x). Note the tier and prior authorization requirement. Tier varies by plan.
- 2
Work with your prescriber on the OptumRx PA submission
Your prescriber must document your confirmed T2D diagnosis, A1c of 6.5% or higher, and prior use of metformin or a documented contraindication. Submit the prior authorization through your prescriber's office via OptumRx; allow up to 72 hours for standard review.
- 3
Call UnitedHealthcare member services to confirm coverage and weight-loss vs diabetes distinction
Call the number on the back of your UHC card. Ask: Is Mounjaro covered for type 2 diabetes on my plan? What tier and copay apply? Is Mounjaro covered for weight loss? (Answer: No — weight-loss tirzepatide is Zepbound, and that requires BMI criteria and employer opt-in.) Confirm whether your employer benefit includes the anti-obesity medication (AOM) benefit.
Options if UnitedHealthcare won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Commonly covered by OptumRx for T2D with prior authorization, often at a preferred or non-preferred tier on UHC plans.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative frequently on preferred tiers with lower list price than Mounjaro on UHC formularies.
Jardiance (empagliflozin)
SGLT2 inhibitor approved for T2D with cardiovascular benefits. Often at preferred tiers on UHC commercial and Medicaid plans.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro (tirzepatide) but FDA-approved for chronic weight management — not diabetes. UHC/OptumRx requires BMI of 30 or higher (or 27 or higher with comorbidity) and employer benefit plan opt-in for weight-loss GLP-1 coverage. This is entirely separate from Mounjaro's T2D coverage.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. UnitedHealthcare does not cover Mounjaro for weight loss under any line of business. Mounjaro is FDA-approved for type 2 diabetes only. Off-label weight-loss requests coded with obesity diagnoses are denied by OptumRx. For weight loss, the same active ingredient (tirzepatide) is Zepbound, which requires a BMI of 30 or higher (or 27 or higher with comorbidity) and is available only when the employer has purchased the anti-obesity medication benefit.
UnitedHealthcare uses OptumRx as its pharmacy benefit manager. OptumRx manages the prior authorization for Mounjaro, requiring a confirmed type 2 diabetes diagnosis and documented metformin step therapy. Tier placement varies by plan — use the OptumRx drug lookup tool or call UHC member services to confirm your specific plan's formulary placement.
All three major PBM-owned carriers cover Mounjaro for T2D with PA, but tier placement differs. Aetna (CVS Caremark) places Mounjaro as a preferred brand with documented A1c and metformin PA. Cigna (Express Scripts) places it as non-preferred specialty Tier 4/5 with 25-33% coinsurance. UHC (OptumRx) covers it with confirmed T2D but tier varies by plan — the middle of the three in terms of documented tier specificity.
UHC via OptumRx requires a confirmed type 2 diabetes diagnosis (ICD-10 E11.x), A1c of 6.5% or greater, and documented trial or failure of metformin (and often one additional agent). Patient must be 18 or older. Quantity limit is typically 4 pens per 28 days. Your prescriber submits the PA through OptumRx. Verify criteria on the UHC/OptumRx formulary or member portal.
Only if you have a UHC commercial (employer-sponsored or individual) plan, not Medicare or Medicaid. Commercially insured members with Mounjaro coverage may pay as little as $25/month; without coverage, $499/month (max $647/month; up to 13 fills; expires 12/31/2026). The card is not available to UHC Medicare Part D, Medicare Advantage, or Medicaid beneficiaries.
Related Articles
Does Blue Cross Blue Shield of Michigan Cover Mounjaro? | Curex
BCBS of Michigan covers Mounjaro for type 2 diabetes with PA, not weight loss. Zepbound weight-loss exclusion upheld by MI DIFS in 2025.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield Cover Mounjaro? 2026 Guide | Curex
BCBS covers Mounjaro for type 2 diabetes with prior authorization — not for weight loss. The weight-loss tirzepatide is Zepbound, with separate coverage.
Read moreDoes Blue Cross Blue Shield of Arizona Cover Mounjaro? | Curex
BCBS of Arizona covers Mounjaro for type 2 diabetes with prior auth — not weight loss. AZ Medicaid covers Wegovy for weight loss, but not Mounjaro.
Read moreDoes Blue Cross Blue Shield of Texas Cover Mounjaro? 2026 | Curex
BCBS of Texas covers Mounjaro for type 2 diabetes with prior auth — not weight loss. The weight-loss tirzepatide is Zepbound, covered separately.
Read moreDoes Blue Cross Blue Shield of Illinois Cover Mounjaro? HCSC 2026 | Curex
BCBS of Illinois (HCSC) covers Mounjaro for type 2 diabetes with PA — not weight loss. IL Medicaid covers T2D but excludes weight-loss GLP-1s.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
UnitedHealthcare covers Mounjaro for diabetes only, not weight loss — its weight-loss GLP-1 coverage (Wegovy/Zepbound) is BMI-gated and employer-dependent. For patients who want tirzepatide access without insurance, compounded tirzepatide from $149/mo (and compounded semaglutide from $49/mo) is available at getcurex.com/cl/glp — no insurance required, no prior authorization. This is compounded tirzepatide and is not the same medication as Mounjaro or Zepbound. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with UnitedHealthcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.